Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Daptomycin IV Dosing for Adults

Standard FDA-Approved Dosing

  • The FDA-approved dose for S. aureus bacteremia and right-sided endocarditis is 6 mg/kg IV once every 24 hours for 2-6 weeks, with duration depending on complexity, according to the American Heart Association 1, 2
  • Duration of treatment depends on complexity: 2 weeks for uncomplicated bacteremia, 4-6 weeks for complicated bacteremia or endocarditis, as recommended by the Infectious Diseases Society of America 2
  • The American Heart Association recommends 8-10 mg/kg IV once daily for left-sided endocarditis and complicated MRSA infections, which may reduce treatment-emergent resistance and are generally well tolerated 1, 3
  • Higher doses of 8-10 mg/kg IV once daily are supported by expert consensus for complicated infections, including left-sided endocarditis, as stated by the American College of Cardiology 1, 3

Important Contraindications and Incompatibilities

  • Daptomycin is contraindicated for pneumonia due to inhibition by pulmonary surfactant, but is effective for septic pulmonary emboli from bacteremia, as noted by the American Thoracic Society 1, 3

Combination Therapy Recommendations

  • The Infectious Diseases Society of America recommends against adding gentamicin to daptomycin for bacteremia or native valve endocarditis, as it does not improve outcomes and may prolong bacteremia duration 2